Hims & Hers Shares Surge on Canaccord Upgrade Amid GLP-1 Shift
Hims & Hers shares climbed 9.5% to $37.97 after Canaccord Genuity raised its target to $40, reflecting a 25% bump. The company's GLP-1 strategy and Medicare's new Bridge program are reshaping the weight-loss drug market.
Markets
